Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0320
-0.0036 (-10.11%)
At close: Oct 1, 2026
Nymox Pharmaceutical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
3.36M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zeo ScientifiX | 6.99M |
| Adaptimmune Therapeutics | 5.92M |
| OSR Health | 1.81M |
| Oncotelic Therapeutics | 250.00K |
| ZIVO Bioscience | 209.03K |
Nymox Pharmaceutical News
- 3 months ago - Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean - Accesswire
- 4 months ago - NYMOX Provides Current Update - Accesswire
- 6 months ago - NYMOX Provides Recent Updates - Accesswire
- 1 year ago - Nymox Announces Dismissal of Delaware Action Against Ascella - GlobeNewsWire
- 1 year ago - Nymox resumes trading with listing on OTCQB - TheFly
- 1 year ago - NYMOX Announces Trading Resumed and New Listing on OTCQB Market - GlobeNewsWire
- 2 years ago - Nymox Announces Filing of Annual Report - GlobeNewsWire
- 2 years ago - Nymox Annual Report - GlobeNewsWire